Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHA/600201 stock hub

SHA/600201 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHA/600201is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

16.5B

Shanghai Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHA/600201

In the news

Latest news · SHA/600201

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E62.9

P25 17.1P50 24.2P75 37.8

Trailing P/E167.7

P25 23.5P50 41.3P75 83.2

ROE1.8

P25 -0.9P50 4.1P75 8.8

ROIC0.6

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHA/600201 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

242

Groups with data

Currency

CNY

Showing 242 of 242 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	1,740
Employees Change	86%
Employees Change Percent	5.2
Enterprise value	CNY 15.3B
Exchange	Shanghai Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE000000Y37
Last refreshed	2026-05-10
Market cap	CNY 16.5B
Price	CNY 15.09
Price currency	CNY
Rev Per Employee	799,599.94x
Sector	Healthcare
Sic	2836
Symbol	sha/600201
Website	https://www.jinyu.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	0.63%
EV Earnings	146.62x
EV/EBITDA	59.47x
EV/FCF	98.37x
EV/Sales	10.95x
FCF yield	0.94%
Forward P/E	62.88x
P/B ratio	2.96x
P/E ratio	167.67x
P/S ratio	11.85x
PE Ratio10 Y	59.66x
PE Ratio3 Y	84.75x
PE Ratio5 Y	69.23x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	1.85%
EBITDA Margin	20.6%
FCF margin	11.17%
Gross margin	52.11%
Gross Profit	CNY 724.9M
Gross Profit Growth	13.54%
Gross Profit Growth Q	-3.34%
Gross Profit Growth3 Y	-5.54%
Gross Profit Growth5 Y	-7.2%
Net Income	CNY 104.3M
Net Income Growth	30.54%
Net Income Growth Q	5.44%
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Net Income Growth3 Y	-23.88%
Net Income Growth5 Y	-25.91%
Pretax Margin	7.57%
Profit Margin	7.49%
Profit Per Employee	CNY 59,927
Profitable Years	31
ROA	0.24
Roa5y	1.79
ROCE	0.44
ROE	1.82
Roe5y	3.9
ROIC	0.58
Roic5y	4.39

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	1.26%
Cagr15y	10.32%
Cagr1y	118.18%
Cagr20y	16.3%
Cagr3y	13.87%
Cagr5y	-5.63%
Div CAGR10	-9.61%
Div CAGR3	-35.15%
Div CAGR5	-12.94%
EPS Growth	27.28
EPS Growth Quarters	1
EPS Growth Years	0
EPS Growth3 Y	-24.81
EPS Growth5 Y	-26.04
FCF Growth	-23.3%
FCF Growth3 Y	0.93%
FCF Growth5 Y	-18.99%
OCF Growth	11.56%
OCF Growth Q	-56.49%
OCF Growth10 Y	-6.39%
OCF Growth3 Y	-3.08%
OCF Growth5 Y	-14.94%
Revenue Growth	10.5x
Revenue Growth Q	-1.45x
Revenue Growth Years	1x
Revenue Growth3 Y	-3.56x
Revenue Growth5 Y	-4.32x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.21
Assets	CNY 6.5B
Cash	CNY 1.3B
Current Assets	CNY 2.4B
Current Liabilities	CNY 648.3M
Debt	CNY 1.2M
Debt EBITDA	CNY 0
Debt Equity	CNY 0
Debt FCF	CNY 0.01
Equity	CNY 5.6B
Interest Coverage	54.72
Liabilities	CNY 972.9M
Long Term Assets	CNY 4.2B
Long Term Liabilities	CNY 324.6M
Net Cash	CNY 1.3B
Net Cash By Market Cap	CNY 8
Net Cash Growth	28.1%
Net Debt EBITDA	CNY -4.6
Net Debt Equity	CNY -0.24
Net Debt FCF	CNY -8.48
Tangible Book Value	CNY 4.9B
Tangible Book Value Per Share	CNY 4.26
WACC	8.59

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.66
Inventory Turnover	2.45
Net Working Capital	CNY 408.2M
Quick ratio	3.19
Working Capital	CNY 1.7B
Working Capital Turnover	CNY 0.88

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.56%
Dividend Growth	-62.5%
Dividend Growth Years	0%
Dividend per share	CNY 0.04
Dividend Years	14
Dividend Yield	0.25%
Ex Div Date	2025-06-26
Last Dividend	CNY 0.03
Payout Frequency	Annual
Payout Ratio	31.87%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	13.37%
1Y total return	118.06%
200-day SMA	12.58
3Y total return	47.65%
50-day SMA	14.73
50-day SMA vs 200-day SMA	50over200
5Y total return	-25.15%
All Time High	31.15
All Time High Change	-51.56%
All Time High Date	2020-08-10
All Time Low	0.54
All Time Low Change	2,671.86%
All Time Low Date	2005-12-05
ATR	0.5
Beta	0.79
Beta1y	0.84
Beta2y	0.95
Ch YTD	0.13
High	15.3
High52	19
High52 Date	2026-01-28
High52ch	-20.58%
Low	14.91
Low52	6.92
Low52 Date	2025-05-08
Low52ch	118.06%
Ma50ch	2.42%
Price vs 200-day SMA	19.99%
RSI	57.99
RSI Monthly	64.33
RSI Weekly	56.76
Sharpe ratio	1.87x
Sortino ratio	3.18
Total Return	-2.32%
Tr YTD	0.13
Tr15y	336.13%
Tr1m	-0.2%
Tr1w	2.93%
Tr3m	-3.39%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 25.7M
Operating Income Growth Q	55.59
Operating Income Growth3 Y	-54.33
Operating Income Growth5 Y	-44.23
Operating margin	1.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	923,986,398%
Net Borrowing	-16,739,621
Shares Insiders	3.43%
Shares Institutions	15.68%
Shares Out	1,092,732,926
Shares Qo Q	-5.81%
Shares Yo Y	2.56%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 155.4M
Average Volume	23,765,690.7x
Bv Per Share	4.74
CAPEX	CNY -145.9M
Ch10y	1.75
Ch15y	279.1
Ch1m	-0.2
Ch1w	2.93
Ch1y	117.1
Ch20y	1,614.6
Ch3m	-3.39
Ch3y	44.4
Ch5y	-28.18
Ch6m	43.44
Change	1.48%
Change From Open	0.73
Close	14.87
Days Gap	0.74
Depreciation Amortization	260,825,312
Dollar Volume	467,794,768.4
Earnings Date	2026-04-23
EBIT	CNY 25.7M
EBITDA	CNY 286.6M
EPS	CNY 0.09
F Score	7
FCF	CNY 155.4M
FCF EV Yield	1.02x
FCF Per Share	CNY 0.14
Financing CF	-284,654,164
Fiscal Year End	December
Founded	1,992
Goodwill	8,195,770
Graham Number	3.14115
Graham Upside	-79.18
Income Tax	CNY 5.3M
Investing CF	-116,587,652
Is Primary Listing	1
Last Earnings Date	2026-04-23
Last Report Date	2026-03-31
Last Split Date	2018-06-25
Last Split Type	Forward
Lynch Fair Value	CNY 0.46
Lynch Upside	-96.93
Ma150	13.9
Ma150ch	8.53%
Ma20	14.54
Ma20ch	3.82%
Net CF	-99,935,400
Next Earnings Date	2026-08-24
Open	14.98
P FCF Ratio	106.1
P OCF Ratio	54.73
Payment Date	2025-06-26
Position In Range	46.15
Ppne	1,842,342,522
Price Date	2026-05-08
Price EBITDA	CNY 57.54
Ptbv Ratio	3.36
Relative Volume	1.33x
Revenue	1,391,303,891x
Tax By Revenue	0.38x
Tax Rate	5.07%
Tr20y	1,950.55%
Tr6m	43.44%
Volume	31,000,316

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHA/600201 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.2%

$0.04 annual per share

Payout ratio

+31.9%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-12.9%

0 consecutive years of growth

Total shareholder yield

-2.3%

Next ex-dividend date: 2025-06-26

Performance

SHA/600201 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHA/600201?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.7%

Share of float held by funds and institutions

Insider ownership

+3.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+2.6%

Negative means the company is buying back shares.

Technical

SHA/600201 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.0

Neutral momentum band

Price vs 200-day MA

+20.0%

50/200-day relationship not available

Beta (5Y)

0.79

Less volatile than the market

Sharpe ratio

1.87

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHA/600201

Hub-level FAQ points readers to the deeper analysis pages.

What is the current sha/600201 stock rating?

sha/600201 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full sha/600201 analysis?

The full report lives at /stocks/sha/600201/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for sha/600201?

The latest report frames sha/600201 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the sha/600201 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.